Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms

European Journal of Pain (United Kingdom)

Volumn 20, Issue 2, 2016, Pages 151-165

  Cury, R G ^a,b   Galhardoni, R ^a   Fonoff, E T ^a   Perez Lloret, S ^c   Dos Santos Ghilardi, M G ^a   Barbosa, E R ^a   Teixeira, M J ^a,b   Ciampi De Andrade, D ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Oncology Center Instituto do Cancer do Estado de Sao Paulo   (Brazil)

^c PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LEVODOPA; ANTIPARKINSON AGENT;

ABLATION THERAPY; ANTINOCICEPTION; BASAL GANGLION; BRADYKINESIA; BRAIN DEPTH STIMULATION; DOPAMINERGIC SYSTEM; EVOKED RESPONSE; HUMAN; MOTOR CONTROL; MOTOR DYSFUNCTION; NOCICEPTION; PAIN; PAIN INTENSITY; PAIN THRESHOLD; PALLIDOTOMY; PARKINSON DISEASE; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; REVIEW; SENSORY DYSFUNCTION; TREMOR; ANALGESIA; COMPLICATION; PARESTHESIA; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; TREATMENT OUTCOME;

ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; HUMANS; PAIN; PAIN MANAGEMENT; PAIN THRESHOLD; PARESTHESIA; PARKINSON DISEASE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84957842197     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/ejp.745     Document Type: Review

References (122)

1. Altier, N., Stewart, J., (1998). Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther 285, 208-215.
2. Altier, N., Stewart, J., (1999). The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65, 2269-2287.
3. Baev, K.V., (1995). Disturbances of learning processes in the basal ganglia in the pathogenesis of Parkinson's disease: A novel theory. Neurol Res 17, 38-48.
4. Baron, M.S., Vitek, J.L., Bakay, R.A., Green, J., Kaneoke, Y., Hashimoto, T., Turner, R.S., Woodard, J.L., Cole, S.A., McDonald, W.M., DeLong, M.R., (1996). Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 40, 355-366.
5. Battista, A.F., Wolff, B., (1973). Levodopa and induced-pain response: A study of patients with parkinsonian and pain syndromes. Arch Intern Med 132, 70-74.
6. Becker, S., Gandhi, W., Elfassy, N.M., Schweinhardt, P., (2013). The role of dopamine in the perceptual modulation of nociceptive stimuli by monetary wins or losses. Eur J Neurosci 38, 3080-3088.
7. Beiske, A.G., Loge, J.H., Rønningen, A., Svensson, E., (2009). Pain in Parkinson's disease: Prevalence and characteristics. Pain 141, 173-177.
8. Benazzouz, A., Hallett, M., (2000). Mechanism of action of deep brain stimulation. Neurology 55, S13-S16.
9. Ben-Sreti, M.M., Gonzalez, J.P., Sewell, R.D., (1983). Differential effects of SKF 38393 and LY 141865 on nociception and morphine analgesia. Life Sci 33 (Suppl 1), 665-668.
10. Berger, B., Gaspar, P., Verney, C., (1991). Dopaminergic innervation of the cerebral cortex: Unexpected differences between rodents and primates. Trends Neurosci 14, 21-27.
11. Borsook, D., Upadhyay, J., Chudler, E.H., Becerra, L., (2010). A key role of the basal ganglia in pain and analgesia-insights gained through human functional imaging. Mol Pain 6, 27.
12. Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., Rüb, U., (2002). Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249 (Suppl 3), III/1-III/5.
13. Braz, J.M., Nassar, M.A., Wood, J.N., Basbaum, A.I., (2005). Parallel "pain" pathways arise from subpopulations of primary afferent nociceptor. Neuron 47, 787-793.
14. Brefel-Courbon, C., Payoux, P., Thalamas, C., Ory, F., Quelven, I., Chollet, F., Montastruc, J.L., Rascol, O., (2005). Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study. Mov Disord 20, 1557-1563.
15. Broen, M.P.G., Braaksma, M.M., Patijn, J., Weber, W.E.J., (2012). Prevalence of pain in Parkinson's disease: A systematic review using the modified QUADAS tool. Mov Disord 27, 480-484.
16. Cao, H., Xu, X., Zhao, Y., Long, D., Zhang, M., (2011). Altered brain activation and connectivity in early Parkinson disease tactile perception. AJNR Am J Neuroradiol 32, 1969-1974.
17. Chaudhuri, K.R., Odin, P., (2010). The challenge of non-motor symptoms in Parkinson's disease. Prog Brain Res 184, 325-341.
18. Chaudhuri, K.R., Schapira, A.H.V., (2009). Non-motor symptoms of Parkinson's disease: Dopaminergic pathophysiology and treatment. Lancet Neurol 8, 464-474.
19. Chaudhuri, K.R., Prieto-Jurcynska, C., Naidu, Y., Mitra, T., Frades-Payo, B., Tluk, S., Ruessmann, A., Odin, P., Macphee, G., Stocchi, F., Ondo, W., Sethi, K., Schapira, A.H.V., Martinez Castrillo, J.C., Martinez-Martin, P., (2010). The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire. Mov Disord 25, 704-709.
20. Chudler, E.H., (1998). Response properties of neurons in the caudate-putamen and globus pallidus to noxious and non-noxious thermal stimulation in anesthetized rats. Brain Res 812, 283-288.
21. Chudler, E.H., Dong, W.K., (1995). The role of the basal ganglia in nociception and pain. Pain 60, 3-38.
22. Chudler, E.H., Sugiyama, K., Dong, W.K., (1995). Multisensory convergence and integration in the neostriatum and globus pallidus of the rat. Brain Res 674, 33-45.
23. Ciampi de Andrade, D., Lefaucheur, J.-P., Galhardoni, R., Ferreira, K.S.L., Brandão Paiva, A.R., Bor-Seng-Shu, E., Alvarenga, L., Myczkowski, M.L., Marcolin, M.A., de Siqueira, S.R.D.T., Fonoff, E., Barbosa, E.R., Teixeira, M.J., (2012). Subthalamic deep brain stimulation modulates small fiber-dependent sensory thresholds in Parkinson's disease. Pain 153, 1107-1113.
24. Coffeen, U., Lõpez-Avila, A., Ortega-Legaspi, J.M., del Angel, R., Lõpez-Muñoz, F.J., Pellicer, F., (2008). Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat. Eur J Pain 12, 535-543.
25. Conte, A., Khan, N., Defazio, G., Rothwell, J.C., Berardelli, A., (2013). Pathophysiology of somatosensory abnormalities in Parkinson disease. Nat Rev Neurol 9, 687-697.
26. Cury, R.G., Galhardoni, R., Fonoff, E.T., Dos Santos Ghilardi, M.G., Fonoff, F., Arnaut, D., Myczkowski, M.L., Marcolin, M.A., Bor-Seng-Shu, E., Barbosa, E.R., Teixeira, M.J., Ciampi de Andrade, D., (2014). Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease. Neurology 83, 1403-1409.
27. Dellapina, E., Gerdelat-Mas, A., Ory-Magne, F., Pourcel, L., Galitzky, M., Calvas, F., Simonetta-Moreau, M., Thalamas, C., Payoux, P., Brefel-Courbon, C., (2011). Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study. Mov Disord 26, 153-157.
28. Dellapina, E., Ory-Magne, F., Regragui, W., Thalamas, C., Lazorthes, Y., Rascol, O., Payoux, P., Brefel-Courbon, C., (2012). Effect of subthalamic deep brain stimulation on pain in Parkinson's disease. Pain 153, 2267-2273.
29. Di Chiara, G., Imperato, A., (1988). Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244, 1067-1080.
30. Djaldetti, R., Shifrin, A., Rogowski, Z., Sprecher, E., Melamed, E., Yarnitsky, D., (2004). Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 62, 2171-2175.
31. Djaldetti, R., Yust-Katz, S., Kolianov, V., Melamed, E., Dabby, R., (2007). The effect of duloxetine on primary pain symptoms in Parkinson disease. Clin Neuropharmacol 30, 201-205.
32. Draganski, B., Kherif, F., Klöppel, S., Cook, P.A., Alexander, D.C., Parker, G.J.M., Deichmann, R., Ashburner, J., Frackowiak, R.S.J., (2008). Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia. J Neurosci 28, 7143-7152.
33. Fasano, A., Daniele, A., Albanese, A., (2012). Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol 11, 429-442.
34. Fleetwood-Walker, S.M., Hope, P.J., Mitchell, R., (1988). Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J Physiol 399, 335-348.
35. Ford, B., (1998). Pain in Parkinson's disease. Clin Neurosci 5, 63-72.
36. Ford, B., (2009). Parkinson disease: Pain in Parkinson disease: The hidden epidemic. Nat Rev Neurol 5, 242-243.
37. Ford, B., (2010). Pain in Parkinson's disease. Mov Disord 25 (Suppl 1), S98-S103.
38. Garcia-Larrea, L., Convers, P., Magnin, M., André-Obadia, N., Peyron, R., Laurent, B., Mauguière, F., (2002). Laser-evoked potential abnormalities in central pain patients: The influence of spontaneous and provoked pain. Brain J Neurol 125, 2766-2781.
39. Gerdelat-Mas, A., Simonetta-Moreau, M., Thalamas, C., Ory-Magne, F., Slaoui, T., Rascol, O., Brefel-Courbon, C., (2007). Levodopa raises objective pain threshold in Parkinson's disease: A RIII reflex study. J Neurol Neurosurg Psychiatry 78, 1140-1142.
40. Gierthmühlen, J., Arning, P., Binder, A., Herzog, J., Deuschl, G., Wasner, G., Baron, R., (2010). Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord 25, 1195-1202.
41. Goetz, C.G., Tanner, C.M., Levy, M., Wilson, R.S., Garron, D.C., (1986). Pain in Parkinson's disease. Mov Disord 1, 45-49.
42. Gold, A., Turkalp, Z.T., Munoz, D.G., (2013). Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. Mov Disord 28, 237-240.
43. Haber, S.N., Calzavara, R., (2009). The cortico-basal ganglia integrative network: The role of the thalamus. Brain Res Bull 78, 69-74.
44. Hagelberg, N., Martikainen, I.K., Mansikka, H., Hinkka, S., Någren, K., Hietala, J., Scheinin, H., Pertovaara, A., (2002). Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99, 273-279.
45. Hely, M.A., Morris, J.G.L., Reid, W.G.J., Trafficante, R., (2005). Sydney Multicenter Study of Parkinson's disease: Non-L-dopa-responsive problems dominate at 15 years. Mov Disord 20, 190-199.
46. Hilker, R., Voges, J., Weisenbach, S., Kalbe, E., Burghaus, L., Ghaemi, M., Lehrke, R., Koulousakis, A., Herholz, K., Sturm, V., Heiss, W.D., (2004). Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: Evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 24, 7-16.
47. Honey, C.R., Stoessl, A.J., Tsui, J.K., Schulzer, M., Calne, D.B., (1999). Unilateral pallidotomy for reduction of parkinsonian pain. J Neurosurg 91, 198-201.
48. Jankovic, J., (2008). Parkinson's disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79, 368-376.
49. Jensen, T.S., Smith, D.F., (1982). Dopaminergic effects on tail-flick response in spinal rats. Eur J Pharmacol 79, 129-133.
50. Jensen, T.S., Yaksh, T.L., (1984). Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats. Brain Res 296, 285-293.
51. Jensen, T.S., Baron, R., Haanpää, M., Kalso, E., Loeser, J.D., Rice, A.S.C., Treede, R.D., (2011). A new definition of neuropathic pain. Pain 152, 2204-2205.
52. Jobst, E.E., Melnick, M.E., Byl, N.N., Dowling, G.A., Aminoff, M.J., (1997). Sensory perception in Parkinson disease. Arch Neurol 54, 450-454.
53. Juri, C., Rodriguez-Oroz, M., Obeso, J.A., (2010). The pathophysiological basis of sensory disturbances in Parkinson's disease. J Neurol Sci 289, 60-65.
54. Kanda, T., Tsukagoshi, H., Oda, M., Miyamoto, K., Tanabe, H., (1996). Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy. Acta Neuropathol 91, 145-154.
55. Kassubek, J., Chaudhuri, K.R., Zesiewicz, T., Surmann, E., Boroojerdi, B., Moran, K., Ghys, L., Trenkwalder, C., (2014). Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: A post hoc analysis of the RECOVER study. BMC Neurol 14, 42.
56. Kim, H.-J., Paek, S.H., Kim, J.-Y., Lee, J.-Y., Lim, Y.H., Kim, M.-R., Kim, D.G., Jeon, B.S., (2008). Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol 255, 1889-1894.
57. Kim, H.-J., Park, S.-Y., Cho, Y.-J., Hong, K.-S., Cho, J.-Y., Seo, S.-Y., Lee, D.-H., Jeon, B.S., (2009). Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 287, 200-204.
58. Kim, H.-J., Jeon, B.S., Lee, J.-Y., Paek, S.H., Kim, D.G., (2012). The benefit of subthalamic deep brain stimulation for pain in Parkinson disease: A 2-year follow-up study. Neurosurgery 70, 18-23.
59. Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P.D., Benazzouz, A., LeBas, J.F., Benabid, A.L., Pollak, P., (2003). Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 349, 1925-1934.
60. Kühn, A.A., Williams, D., Kupsch, A., Limousin, P., Hariz, M., Schneider, G.-H., Yarrow, K., Brown, P., (2004). Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain J Neurol 127, 735-746.
61. Kühn, A.A., Kupsch, A., Schneider, G.-H., Brown, P., (2006). Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci 23, 1956-1960.
62. Laitinen, L.V., Bergenheim, A.T., Hariz, M.I., (1992). Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 76, 53-61.
63. Le Jeune, F., Péron, J., Grandjean, D., Drapier, S., Haegelen, C., Garin, E., Millet, B., Vérin, M., (2010). Subthalamic nucleus stimulation affects limbic and associative circuits: A PET study. Eur J Nucl Med Mol Imaging 37, 1512-1520.
64. Le Moal, M., Simon, H., (1991). Mesocorticolimbic dopaminergic network: Functional and regulatory roles. Physiol Rev 71, 155-234.
65. Leone, P., Pocock, D., Wise, R.A., (1991). Morphine-dopamine interaction: Ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 39, 469-472.
66. Leyden, J., Kleinig, T., (2008). The role of the basal ganglia in data processing. Med Hypotheses 71, 61-64.
67. Li, K., Pickett, K., Nestrasil, I., Tuite, P., Konczak, J., (2010). The effect of dopamine replacement therapy on haptic sensitivity in Parkinson's disease. J Neurol 257, 1992-1998.
68. Lim, S.-Y., Farrell, M.J., Gibson, S.J., Helme, R.D., Lang, A.E., Evans, A.H., (2008). Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? Mov Disord 23, 1689-1695.
69. Lin, M.T., Wu, J.J., Chandra, A., Tsay, B.L., (1981). Activation of striatal dopamine receptors induces pain inhibition in rats. J Neural Transm 51, 213-222.
70. Liu, Q.S., Qiao, J.T., Dafny, N., (1992). D2 dopamine receptor involvement in spinal dopamine-produced antinociception. Life Sci 51, 1485-1492.
71. Loher, T.J., Burgunder, J.-M., Weber, S., Sommerhalder, R., Krauss, J.K., (2002). Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 73, 395-399.
72. Lõpez-Avila, A., Coffeen, U., Ortega-Legaspi, J.M., del Angel, R., Pellicer, F., (2004). Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex. Pain 111, 136-143.
73. Lozano, A.M., Dostrovsky, J., Chen, R., Ashby, P., (2002). Deep brain stimulation for Parkinson's disease: Disrupting the disruption. Lancet Neurol 1, 225-231.
74. Magnusson, J.E., Fisher, K., (2000). The involvement of dopamine in nociception: The role of D(1) and D(2) receptors in the dorsolateral striatum. Brain Res 855, 260-266.
75. Márkus, Z., Eördegh, G., Parõczy, Z., Benedek, G., Nagy, A., (2008). Modality distribution of sensory neurons in the feline caudate nucleus and the substantia nigra. Acta Biol Hung 59, 269-279.
76. Marques, A., Chassin, O., Morand, D., Pereira, B., Debilly, B., Derost, P., Ulla, M., Lemaire, J.J., Durif, F., (2013). Central pain modulation after subthalamic nucleus stimulation: A crossover randomized trial. Neurology 81, 633-640.
77. Martikainen, I.K., Hagelberg, N., Mansikka, H., Hietala, J., Någren, K., Scheinin, H., Pertovaara, A., (2005). Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia. Neurosci Lett 376, 149-153.
78. Maruo, T., Saitoh, Y., Hosomi, K., Kishima, H., Shimokawa, T., Hirata, M., Goto, T., Morris, S., Harada, Y., Yanagisawa, T., Aly, M.M., Yoshimine, T., (2011). Deep brain stimulation of the subthalamic nucleus improves temperature sensation in patients with Parkinson's disease. Pain 152, 860-865.
79. Maschke, M., Gomez, C.M., Tuite, P.J., Konczak, J., (2003). Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia. Brain J Neurol 126, 2312-2322.
80. Mongeon, D., Blanchet, P., Messier, J., (2009). Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing. Neuroscience 158, 426-440.
81. Mylius, V., Engau, I., Teepker, M., Stiasny-Kolster, K., Schepelmann, K., Oertel, W.H., Lautenbacher, S., Möller, J.C., (2009). Pain sensitivity and descending inhibition of pain in Parkinson's disease. J Neurol Neurosurg Psychiatry 80, 24-28.
82. Mylius, V., Borckardt, J.J., Lefaucheur, J.-P., (2012). Noninvasive cortical modulation of experimental pain. Pain 153, 1350-1363.
83. Nandhagopal, R., Troiano, A.R., Mak, E., Schulzer, M., Bushnell, M.C., Stoessl, A.J., (2010). Response to heat pain stimulation in idiopathic Parkinson's disease. Pain Med 11, 834-840.
84. Nègre-Pagès, L., Regragui, W., Bouhassira, D., Grandjean, H., Rascol, O., (2008). Chronic pain in Parkinson's disease: The cross-sectional French DoPaMiP survey. Mov Disord 23, 1361-1369.
85. Nolano, M., Provitera, V., Estraneo, A., Selim, M.M., Caporaso, G., Stancanelli, A., Saltalamacchia, A.M., Lanzillo, B., Santoro, L., (2008). Sensory deficit in Parkinson's disease: Evidence of a cutaneous denervation. Brain J Neurol 131, 1903-1911.
86. Oshima, H., Katayama, Y., Morishita, T., Sumi, K., Otaka, T., Kobayashi, K., Suzuki, Y., Fukaya, C., Yamamoto, T., (2012). Subthalamic nucleus stimulation for attenuation of pain related to Parkinson disease. J Neurosurg 116, 99-106.
87. Park, A., Stacy, M., (2009). Non-motor symptoms in Parkinson's disease. J Neurol 256 (Suppl 3), 293-298.
88. Pellaprat, J., Ory-Magne, F., Canivet, C., Simonetta-Moreau, M., Lotterie, J.-A., Radji, F., Arbus, C., Gerdelat, A., Chaynes, P., Brefel-Courbon, C., (2014). Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease. Parkinsonism Relat Disord 20, 662-664.
89. Perrotta, A., Sandrini, G., Serrao, M., Buscone, S., Tassorelli, C., Tinazzi, M., Zangaglia, R., Pacchetti, C., Bartolo, M., Pierelli, F., Martignoni, E., (2011). Facilitated temporal summation of pain at spinal level in Parkinson's disease. Mov Disord 26, 442-448.
90. Pertovaara, A., Martikainen, I.K., Hagelberg, N., Mansikka, H., Någren, K., Hietala, J., Scheinin, H., (2004). Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain. Eur J Neurosci 20, 1587-1592.
91. Picarelli, H., Teixeira, M.J., de Andrade, D.C., Myczkowski, M.L., Luvisotto, T.B., Yeng, L.T., Fonoff, E.T., Pridmore, S., Marcolin, M.A., (2010). Repetitive transcranial magnetic stimulation is efficacious as an add-on to pharmacological therapy in complex regional pain syndrome (CRPS) type I. J Pain 11, 1203-1210.
92. Porro, C.A., Cavazzuti, M., Baraldi, P., Giuliani, D., Panerai, A.E., Corazza, R., (1999). CNS pattern of metabolic activity during tonic pain: Evidence for modulation by beta-endorphin. Eur J Neurosci 11, 874-888.
93. Prodoehl, J., Yu, H., Wasson, P., Corcos, D.M., Vaillancourt, D.E., (2008). Effects of visual and auditory feedback on sensorimotor circuits in the basal ganglia. J Neurophysiol 99, 3042-3051.
94. Quittenbaum, B.H., Grahn, B., (2004). Quality of life and pain in Parkinson's disease: A controlled cross-sectional study. Parkinsonism Relat Disord 10, 129-136.
95. Ray, N.J., Jenkinson, N., Wang, S., Holland, P., Brittain, J.S., Joint, C., Stein, J.F., Aziz, T., (2008). Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp Neurol 213, 108-113.
96. Reichling, D.B., Levine, J.D., (2011). Pain and death: Neurodegenerative disease mechanisms in the nociceptor. Ann Neurol 69, 13-21.
97. Saadé, N.E., Shbeir, S.A., Atweh, S.F., Jabbur, S.J., (1996). Effects of cerebral cortical and striatal lesions on autotomy following peripheral neurectomy in rats. Physiol Behav 60, 559-566.
98. Saadé, N.E., Atweh, S.F., Bahuth, N.B., Jabbur, S.J., (1997). Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res 751, 1-12.
99. Samii, A., Nutt, J.G., Ransom, B.R., (2004). Parkinson's disease. Lancet 363, 1783-1793.
100. Sánchez-González, M.A., García-Cabezas, M.A., Rico, B., Cavada, C., (2005). The primate thalamus is a key target for brain dopamine. J Neurosci 25, 6076-6083.
101. Schestatsky, P., Kumru, H., Valls-Solé, J., Valldeoriola, F., Marti, M.J., Tolosa, E., Chaves, M.L., (2007). Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 69, 2162-2169.
102. Schultz, W., (1998). Predictive reward signal of dopamine neurons. J Neurophysiol 80, 1-27.
103. Scott, D.J., Heitzeg, M.M., Koeppe, R.A., Stohler, C.S., Zubieta, J.-K., (2006). Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci 26, 10789-10795.
104. Scott, D.J., Stohler, C.S., Koeppe, R.A., Zubieta, J.-K., (2007). Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge. Synapse 61, 707-714.
105. Simon, H., Le Moal, M., Calas, A., (1979). Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase. Brain Res 178, 17-40.
106. Slaoui, T., Mas-Gerdelat, A., Ory-Magne, F., Rascol, O., Brefel-Courbon, C., (2007). Levodopa modifies pain thresholds in Parkinson's disease patients. Rev Neurol (Paris) 163, 66-71.
107. Snider, S.R., Fahn, S., Isgreen, W.P., Cote, L.J., (1976). Primary sensory symptoms in parkinsonism. Neurology 26, 423-429.
108. Spanagel, R., Herz, A., Shippenberg, T.S., (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 89, 2046-2050.
109. Spielberger, S., Wolf, E., Kress, M., Seppi, K., Poewe, W., (2011). The influence of deep brain stimulation on pain perception in Parkinson's disease. Mov Disord 26, 1367-1368.
110. Storch, A., Schneider, C.B., Wolz, M., Stürwald, Y., Nebe, A., Odin, P., Mahler, A., Fuchs, G., Jost, W.H., Chaudhuri, K.R., Koch, R.H., (2013). Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80, 800-809.
111. Sürücü, O., Baumann-Vogel, H., Uhl, M., Imbach, L.L., Baumann, C.R., (2013). Subthalamic deep brain stimulation versus best medical therapy for L-dopa responsive pain in Parkinson's disease. Pain 154, 1477-1479.
112. Tashev, R., Belcheva, S., Milenov, K., Belcheva, I., (2001). Antinociceptive effect of somatostatin microinjected into caudate putamen. Peptides 22, 1079-1083.
113. Tinazzi, M., Del Vesco, C., Fincati, E., Ottaviani, S., Smania, N., Moretto, G., Fiaschi, A., Martino, D., Defazio, G., (2006). Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 77, 822-825.
114. 2 laser evoked potentials. Pain 136, 117-124.
115. Tolosa, E., Compta, Y., Gaig, C., (2007). The premotor phase of Parkinson's disease. Parkinsonism Relat Disord 13, S2-S7.
116. Treede, R.-D., Jensen, T.S., Campbell, J.N., Cruccu, G., Dostrovsky, J.O., Griffin, J.W., Hansson, P., Hughes, R., Nurmikko, T., Serra, J., (2008). Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 70, 1630-1635.
117. Trost, M., Su, S., Su, P., Yen, R.-F., Tseng, H.-M., Barnes, A., Ma, Y., Eidelberg, D., (2006). Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. NeuroImage 31, 301-307.
118. Wager, T.D., Matre, D., Casey, K.L., (2006). Placebo effects in laser-evoked pain potentials. Brain Behav Immun 20, 219-230.
119. Whitmer, D., de Solages, C., Hill, B., Yu, H., Henderson, J.M., Bronte-Stewart, H., (2012). High frequency deep brain stimulation attenuates subthalamic and cortical rhythms in Parkinson's disease. Front Hum Neurosci 6, 155.
120. Witjas, T., Kaphan, E., Régis, J., Jouve, E., Chérif, A.A., Péragut, J.C., Azulay, J.P., (2007). Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov. Disord. 22, 1729-1734.
121. Wolz, M., Hauschild, J., Koy, J., Fauser, M., Klingelhöfer, L., Schackert, G., Reichmann, H., Storch, A., (2012). Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease. Parkinsonism Relat Disord 18, 994-997.
122. Zibetti, M., Torre, E., Cinquepalmi, A., Rosso, M., Ducati, A., Bergamasco, B., Lanotte, M., Lopiano, L., (2007). Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur. Neurol. 58, 218-223.